STOCKHOLDERS' EQUITY (Tables)

12 Months Ended

Dec. 31, 2014

Summary of changes in restricted share and option awards outstanding

	Restricted shares				Options
	Shares		Wtd. Avg. Grant Price		Shares		Wtd. Avg. Ex. Price			Aggregate Intrinsic Value
December 31, 2011	71		$	37.85	292		$	25.15		$	1,110
Granted	29		24.16		63		24.16			302
Vested or Exercised	(44	)	37.61		(11	)	6.49			(247		)
Forfeited	(6	)	28.55		(3	)	(20.19		)	(147		)
December 31, 2012	50		$	31.35	341		$	25.62		1,136
Granted	58		20.29		68		20.71			560
Vested or Exercised	(8	)	19.57		(2	)	12.29			(33		)
Forfeited	—		—		(24	)	(30.29		)	(1,422		)
December 31, 2013	100		$	24.12	383		$	24.52		1,697
Granted	61		23.27		70		24.28			327
Vested or Exercised	(39	)	27.35		(13	)	2.87			(339		)
Forfeited	—		—		(13	)	(24.57		)	(696		)
December 31, 2014	122		$	22.68	427		$	24.89		1,734

Summary of information about stock options

	Options Outstanding				Options Exercisable
Range of Exercise Price	Shares	Wtd. Avg. Remaining Contractual Life	Wtd. Avg. Exercise Price		Shares	Wtd. Avg. Remaining Contractual Life	Wtd. Avg. Exercise Price
$0.00-20.00	116	2.51	$	19.41	106	2.25	$	19.40
$20.01-30.00	214	7.60	$	22.91	80	5.38	$	22.62
Over $30.00	97	4.68	$	35.88	87	4.68	$	35.80
	427	5.55	$	24.89	273	3.95	$	25.59

Schedule of exercisable options and related information

	2014		2013		2012
Exercisable at end of year	273		259		240
Weighted average price	$	25.59	$	24.89	$	24.33

Weighted average fair value of options granted during the year	$	11.61	$	9.59	$	10.92

Schedule of unvested options

	Shares		Wtd. Avg. Ex. Price
December 31, 2013	124		$	23.77
Vested	38		25.08
Granted	70		24.28
Forfeited	(2	)	(25.75		)
December 31, 2014	154		$	23.65

Schedule of assumptions used in determining the fair value option awards

Grant date		Equivalent interest rate		Equivalent volatility		Implied expected lives
March 17, 2014		2.68	%	40.00	%	8.32

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details